- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03956784
E-assisted Follow up Diagnosis of Post Operative Digestive Complications (SURGICONNECT)
Impact of E-assisted Connected Follow up on the Delay of Management of Postoperative Complications in Digestive Surgery
Postoperative management in digestive surgery has been modernized thanks to improved rehabilitation measures. These measures include an earlier refeeding, mobilization, restriction of infusions (out of a total of 22) and showed their benefit in colorectal, gastric and bariatric surgery. It is thus possible to perform sleeve gastrectomy, bypass, restorations of digestive continuity and colectomies with early discharge or one day surgery.
The most serious complications (fistula, sepsis) occur in the first 10 days postoperatively with an average readmission rate of 10%. Their screening is based on clinical signs (tachycardia, pain) or biological (C-Reactive Protein (CRP) assay on Day 3 or Day 4). It is important to manage these complications early so that their morbidity is lower, resulting in shorter stays and less severity.
The monitoring and safety of patients discharged early are therefore essential and for the moment poorly codified, ranging from simple nursing to follow-up via a health provider. Recently, coordination structures including nurse platform and smartphone follow up app have emerged. Thanks to this system, the patient collects his own history and biological results which allows him to be monitored continuously, as in the hospital. In case of no filling or sign of complication, the nurse platform contacts the patient.
This connected follow-up would make it possible to reinforce the safety of the patient discharged early after a complex digestive procedure performed on an outpatient basis. Its benefit has been poorly evaluated but it is however more and more used by surgeons convinced of its interest especially as it goes in the direction of the development of the outpatient activity requested by the High Authority of Health with economic benefits interesting also the administration of the care structures.
The purpose of the investigator's study is to evaluate the impact of e-assessed follow-up during 10 days after surgery compared to a conventional follow-up. The hypothesis is that this connected follow-up would allow earlier detection of complications requiring rehospitalization (within 48 hours), resulting in faster and less severe treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Arnaud PASQUER, MD
- Phone Number: +33 472.11.69.22
- Email: arnaud.pasquer@chu-lyon.fr
Study Contact Backup
- Name: Dominique DELAUNAY
- Phone Number: +33 472.11.00.64
- Email: Dominique.delaunay@chu-lyon.fr
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- Withdrawn
- Service de Chirurgie Digestive, Hôpital d'Estaing, CHU de Clermont-Fd
-
Dijon, France, 21000
- Withdrawn
- Service de Chirurgie Digestive, Hôpital Le Bocage, CHU Dijon
-
Grenoble, France, 38043
- Recruiting
- Département de Chirurgie Digestive, Hôpital Michallon, CHU Grenoble
-
Contact:
- Jean-Luc FAUCHERON, MD
-
Principal Investigator:
- Jean-Luc FAUCHERON, MD
-
Le Puy en Velay, France, 43012
- Recruiting
- Service de Chirurgie Viscérale et Digestive, CH Emile Roux
-
Contact:
- Luis Matias BRUNAS, MD
-
Principal Investigator:
- Luis Matias BRUNAS, MD
-
Lyon, France, 69004
- Recruiting
- Service de Chirurgie Générale, Digestive et de la Transplantation Hépatique, Hôpital de la Croix Rousse, Hospices Civils de Lyon
-
Contact:
- Kayvan MOHKAM, MD
-
Principal Investigator:
- Kayvan MOHKAM, MD
-
Lyon, France, 69437
- Recruiting
- Service de Chirurgie Digestive, Hôpital Edouard Herriot, Hospices Civils de Lyon
-
Contact:
- Arnaud PASQUER, MD
- Phone Number: +33 472.11.69.22
- Email: arnaud.pasquer@chu-lyon.fr
-
Principal Investigator:
- Arnaud PASQUER, MD
-
Pierre-Bénite, France, 69310
- Recruiting
- Service de Chirurgie Digestive, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon
-
Contact:
- Eddy COTTE, MD
-
Saint-Étienne, France, 42055
- Recruiting
- Service de Chirurgie Digestive et Oncologie Digestive, Hôpital Nord, CHU Saint-Etienne
-
Contact:
- Bertrand LE ROY, MD
-
Principal Investigator:
- Bertrand LE ROY, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient, male or female, age ≥18 years
- Patient hospitalized for colorectal, gastric or bariatric surgery
- Patient for whom an outpatient or enhanced recovery after surgery is performed (expected discharge no later than 4 days after surgery)
- Patient with a computer, tablet or mobile connected to internet
- Patient who agrees to be included in the study and who signs the informed consent form,
- Patient affiliated with a healthcare insurance plan.
Exclusion Criteria:
- Minor patient
- Patient who does not understand French, under supervision or guardianship
- Mentally unbalanced patients or unable to follow the instructions of a connected follow-up, from the point of view of the investigator
- Patient who is unable to give consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: E-assessed follow up
Patients undergoing colorectal surgery (colectomy, sigmoidectomy, proctectomy, digestive stoma closure), bariatric or gastric, for whom an early discharge has been programmed, and followed by a connected application and a nursing logistics platform at home.
|
Clinical questionnaire: self-evaluation of pain (0 to 10), resumption of transit, bleeding, fever, pulse. In case of no filling, the patient is contacted. An automatic alert system is defined and divide the patient according to three situations:
Biological questionnaire: Biological monitoring (blood count, Ionogram, C-Reactive Protein, urea, creatinine) is performed on D1, D3 and D7. All information is accessible in real time by the surgeon who receives notifications by email and on his smartphone in case of clinical or biological abnormality on patient monitoring. |
Other: Standard home follow-up care
Patients undergoing surgery for colorectal surgery (colectomy, sigmoidectomy, proctectomy, digestive stoma closure), bariatric or gastric surgery, for whom an early discharge has been programmed, and followed by usual way.
|
An information sheet on the clinical parameters to be monitored will be given to patients and will include the following information:
Each patient will be given a prescription to perform a C-Reactive Protein assay on D1, D3 and D7, similarly. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time required for the management of post-operative complications requiring rehospitalization
Time Frame: Within 6 months after surgery
|
Number of hours between discharge from hospitalization after digestive surgery and readmission for hospitalization during which medical, surgical, radiological or endoscopic treatment is performed.
|
Within 6 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Severe postoperative complication rate
Time Frame: Within 30 days after surgery
|
Rate of medical and surgical (> or = grade 3) complications within 30 days after surgery using the Dindo-Clavien classification, described as: Grade I = Any deviation from the normal postoperative course. Grade 2 = Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Grade III = Requiring surgical, endoscopic or radiological intervention, not under (Grade IIIa) or under general anesthesia (Grade IIIb) Grade IV = Life-threatening complication with single organ (Grade IVa) or Multiorgan dysfunction (Grade IVb) Grade V = Death of a patient. |
Within 30 days after surgery
|
Early overall complication rate
Time Frame: Within 30 days after surgery
|
Rate of medical and surgical complications (each grade) within 30 days after surgery using the Dindo-Clavien classification
|
Within 30 days after surgery
|
Type of early complications
Time Frame: Within 30 days after surgery
|
Type (medical or surgical) of late complications (after 30 days) for each procedure according to the Dindo-Clavien classification
|
Within 30 days after surgery
|
Severity of early complications
Time Frame: Within 30 days after surgery
|
Severity of late complications (after 30 days) for each procedure according to the Dindo-Clavien classification
|
Within 30 days after surgery
|
Late overall complication rate
Time Frame: Within 6 months after surgery
|
Rate of medical and surgical complications (each grade) within 6 months after surgery using the Dindo-Clavien classification
|
Within 6 months after surgery
|
Type of late complications
Time Frame: Within 6 months after surgery
|
Type (medical or surgical) of late complications (after 6 months) for each procedure according to the Dindo-Clavien classification
|
Within 6 months after surgery
|
Severity of late complications
Time Frame: Within 6 months after surgery
|
Severity of late complications (after 6 months) for each procedure according to the Dindo-Clavien classification
|
Within 6 months after surgery
|
Postoperative mortality
Time Frame: Within 30 days and 6 months after surgery
|
Number of patients who died within 30 days and 6 months after surgery
|
Within 30 days and 6 months after surgery
|
Readmission of patient
Time Frame: Within 30 days and 6 months after surgery
|
Number of patients readmitted within 30 days and 6 months after surgery.
|
Within 30 days and 6 months after surgery
|
Quality of life assessed with SF36 questionnaire
Time Frame: Before surgery and at 10 and 30 days after surgery
|
Before surgery and at 10 and 30 days after surgery, according to the SF36 (Short Form (36) Health Survey) questionnaire. This questionnaire taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/tiredness, and general health perceptions. It also includes a single item that provides an indication of a perceived change in health. |
Before surgery and at 10 and 30 days after surgery
|
Quality of life assessed with GIQLI questionnaire
Time Frame: Before surgery and at 10 and 30 days after surgery
|
Before surgery and at 10 and 30 days after surgery, according to the GIQLI (Gastrointestinal Quality of Life index) questionnaire. This questionnaire consists of 36 items exploring 5 dimensions or subscales: symptoms, physical condition, emotions, social integration and the effect of any medical treatment. For each item, 5 responses will be proposed to the patients and for each answer, a score ranging from 0 to 4 (highest score = 144) will be assigned. A high score defines a more favorable health state. |
Before surgery and at 10 and 30 days after surgery
|
Patient satisfaction: VAS
Time Frame: 10 days after surgery
|
Satisfaction will be measured using a visual analog scale, rated from 0 (no satisfaction) to 10 (Perfect Satisfaction)
|
10 days after surgery
|
Patient sense of security
Time Frame: 10 days after surgery
|
Sence of security will be measured using a visual analog scale, rated from 0 (no security felt) to 10 (Complete security felt Satisfaction)
|
10 days after surgery
|
Costs
Time Frame: 7 months post-inclusion
|
Costs associated with the strategy including the Follow-up care via Mobile App compared to the standard follow-up care strategy.
|
7 months post-inclusion
|
Consequences
Time Frame: 7 months post-inclusion
|
Consequences associated with the strategy including the Follow-up care via Mobile App compared to the standard follow-up care strategy.
|
7 months post-inclusion
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL19_0343
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-operative Complications After Colorectal Surgery
-
Hospices Civils de LyonCompletedPost Operative Care After Cardiac Surgery With Cardio Pulmonary BypassFrance
-
Tanta UniversityUnknownPost Operative Pain After Pediatric Hip SurgeryEgypt
-
University Hospital, Clermont-FerrandCompletedPost Operative Pain | Laparoscopic Colorectal SurgeryFrance
-
Renibus Therapeutics, Inc.RecruitingPost-Operative Complications in Cardiac SurgeryUnited States, Canada
-
Renibus Therapeutics, Inc.RecruitingPost-Operative Complications in Cardiac SurgeryUnited States, Canada
-
Tanta UniversityCompleted
-
Munazzah RafiqueUnknownPost-operative Pain After Posterior Vaginal Repair
-
NorthShore University HealthSystemRecruitingPost Operative Pain | Quality of Recovery After MastectomyUnited States
-
Eun Kyung ChoiCompletedPost Operative Pain | Quality of Recovery After General AnesthesiaKorea, Republic of
-
Indonesia UniversityCompletedAnesthesia | Enhanced Recovery After Surgery | Colorectal | Surgery-Complications | Early MobilizationIndonesia
Clinical Trials on E-assessed clinical and biological follow up
-
University Hospital, MontpellierINSERM 1061, " Neuropsychiatry: epidemiological and clinical research", MontpellierRecruiting
-
University of IcelandMemorial Sloan Kettering Cancer Center; Landspitali University Hospital; deCODE... and other collaboratorsActive, not recruitingMonoclonal Gammopathy of Undetermined SignificanceIceland
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Central Hospital, Nancy, FranceCompleted
-
Takeshi MorimotoCompletedCoronary Artery DiseaseJapan
-
Rennes University HospitalUnknown
-
M.D. Anderson Cancer CenterRecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Second Affiliated Hospital, School of Medicine,...First Affiliated Hospital of Wenzhou Medical University; Jinhua Central Hospital and other collaboratorsRecruitingCoronary Artery DiseaseChina
-
Assistance Publique - Hôpitaux de ParisRecruitingSpinocerebellar Ataxias | Inherited Movement Disorders | Hyperkinetic DisordersFrance
-
Oslo University HospitalCompletedSubarachnoid HemorrhageNorway